“When you love blindly, even flaws seem like virtues.” → When you deeply like or love someone, you may ignore their weaknesses. Their mistakes or shortcomings may even appear charming, acceptable, or even “good” to you. For example, if someone is stubborn, you might call it “determined” because you love them.
“When your dislike is intense, even virtues seem like flaws.” → On the other hand, if you dislike someone, even their positive qualities can appear negative. For instance, if someone is confident, you might see them as arrogant—simply because your attitude toward them is negative.
“Mend Your Attitude” → The key message is that it’s not always the person who is truly good or bad—it’s often our own perspective that is biased. By adjusting your attitude (removing the “blinding” effects of love or dislike), you can see people more clearly and fairly.
Posted: 18 Sep 2025
STANDARD GLASS LINING TECHONOLOGY LIMITED. Details required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 and Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 S. No. Particulars Description 1. Name of the Target Company, details in brief such as size, turnover, etc. Standard Scigenics Private Limited, has been formed as subsidiary company of the Company Registered Office: D-12, Phase-I, IDA Jeedimetla, Tirumalagiri, Hyderabad -500055, Telangana Authorised Share Capital: Rs. 10,00,000/- Date of Incorporation: 16th September 2025 Size/Turnover: Not applicable 2. Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at arms length Standard Scigenics Private Limited is a newly incorporated company and therefore, it is not a related party transaction. 3. Industry to which the entity being acquired belongs Manufacturing 4. Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity) To manufacture, design, develop, assemble, supply, and deal in upstream and downstream process equipment and machinery for biotechnology, biologics, chemical, pharmaceutical, pollution control, industrial process and other industries. 5. Brief details of any governmental or regulatory approvals required for the acquisition Not Applicable 6. Indicative time period for completion of the acquisition Not Applicable 7. Consideration - whether cash consideration or share swap or any other form and details of the same Initial capital subscription in cash
Posted: 01 May 2026
Posted: 08 Apr 2026
Posted: 20 Mar 2026
Posted: 06 Mar 2026
Posted: 27 Feb 2026
Posted: 19 Feb 2026
Posted: 15 Dec 2025
Posted: 03 Dec 2025
Posted: 01 Dec 2025
Posted: 07 Nov 2025
Posted: 06 Nov 2025
Posted: 30 Oct 2025
Posted: 29 Oct 2025
Posted: 28 Oct 2025
Posted: 27 Oct 2025
Be prepared to invest in a down market and to "get out" in a soaring market, as per the philosophy of Warren Buffett.